Erasca (ERAS) Non Operating Income (2020 - 2026)
Erasca (ERAS) posted Non Operating Income of $4.5 million for Q1 2026, up 27.31% on a QoQ basis from $3.5 million in Q4 2025, and down 4.14% year-over-year from $4.7 million in Q1 2025.
Erasca (ERAS) Non Operating Income (2020 - 2026) Analysis & Trends
Erasca's Non Operating Income history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- Quarterly Non Operating Income fell 4.14% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 14.73% YoY) and the FY2025 annual result came in at $16.4 million, down 8.8% from the prior year.
- Non Operating Income was $4.5 million for Q1 2026 at Erasca, up from $3.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $5.9 million in Q3 2024 and bottomed at $47000.0 in Q1 2022.
- A 5-year average of $3.5 million and a median of $3.9 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income jumped 8040.43% — and 2025, when it plunged 32.97%.
- Erasca's Non Operating Income stood at $2.6 million in 2022, then soared by 59.14% to $4.2 million in 2023, then dropped by 16.57% to $3.5 million in 2024, then advanced by 0.92% to $3.5 million in 2025, then climbed by 27.31% to $4.5 million in 2026.
- Business Quant data shows ERAS's Non Operating Income at $4.5 million in Q1 2026, $3.5 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 3.48 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 4.35 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 297,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | -30,000.00 |